ABBOTT LABORATORIES (ABT) Shareholders’ equity 2016–2025
ABBOTT LABORATORIES (ABT) shareholders’ equity at each fiscal year-end, per SEC filings.
$52.1BFY2025 · since FY2016: $20.5B → $52.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $52.1B | +9.4% |
| FY2024 | $47.7B | +23.5% |
| FY2023 | $38.6B | +5.2% |
| FY2022 | $36.7B | +2.5% |
| FY2021 | $35.8B | +9.2% |
| FY2020 | $32.8B | +5.5% |
| FY2019 | $31.1B | +1.8% |
| FY2018 | $30.5B | -1.2% |
| FY2017 | $30.9B | +50.4% |
| FY2016 | $20.5B | — |
Source: SEC XBRL filings · For reference only · Not investment advice